Paul Saladino· MD
it's very clear that excess visceral adiposity this degree of thickness in the body makes me very suspicious about this for elon is highly associated with cardiometabolic disease risk visceral fat and insulin resistance
Loading…
The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
it's very clear that excess visceral adiposity this degree of thickness in the body makes me very suspicious about this for elon is highly associated with cardiometabolic disease risk visceral fat and insulin resistance
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
recent studies have indicated that accumulation of visceral fat rather than subcutaneous fat is associated with increased cardiometabolic risk
and unpack the realities of popular GLP-1 receptor agonist medications (like Ozempic), including their benefits, risks, and the intriguing potential of microdosing.